{"687826":{"#nid":"687826","#data":{"type":"news","title":"Yellow Jacket Connection Sparks Glaucoma Research Fund at Tech","body":[{"value":"\u003Cp dir=\u0022ltr\u0022\u003EAn estimated 4 million Americans have glaucoma, a group of eye diseases that can lead to irreversible blindness.\u0026nbsp;Now, Georgia Tech is home to a Glaucoma Research Fund that will\u0026nbsp;support cutting-edge work to understand and advance treatments for the disease.\u003C\/p\u003E\u003Cp dir=\u0022ltr\u0022\u003EThe new initiative was sparked by ongoing research at Georgia Tech \u2014 and a Yellow Jacket connection: when\u0026nbsp;Postdoctoral Research Fellow\u0026nbsp;\u003Cstrong\u003EHannah Youngblood\u003C\/strong\u003E\u2019s\u0026nbsp;\u003Ca href=\u0022https:\/\/www.brightfocus.org\/news\/a-key-protein-could-alter-risk-for-pseudoexfoliation-glaucoma\/\u0022\u003Ework on exfoliation glaucoma (XFG)\u003C\/a\u003E was featured by the\u0026nbsp;\u003Ca href=\u0022https:\/\/www.brightfocus.org\/\u0022\u003EBrightFocus Foundation\u003C\/a\u003E,\u0026nbsp;it caught the attention of\u0026nbsp;\u003Cstrong\u003EJennifer Rucker,\u0026nbsp;\u003C\/strong\u003Ean Alabama resident who was diagnosed with XFG several years ago.\u003C\/p\u003E\u003Cp dir=\u0022ltr\u0022\u003EExcited that the research could change outcomes for people like her \u2014 and proud that it\u2019s happening at her husband\u0026nbsp;\u003Cstrong\u003EPhilip Rucker\u003C\/strong\u003E\u2019s, EE 72, alma mater \u2014 Jennifer Rucker reached out to Youngblood and her advisor,\u0026nbsp;\u003Ca href=\u0022https:\/\/chemistry.gatech.edu\/\u0022\u003ESchool of Chemistry and Biochemistry\u003C\/a\u003E Professor and Kelly Sepcic Pfeil, Ph.D. Chair\u0026nbsp;\u003Ca href=\u0022https:\/\/research.gatech.edu\/people\/raquel-lieberman\u0022\u003E\u003Cstrong\u003ERaquel Lieberman\u003C\/strong\u003E\u003C\/a\u003E\u003Cstrong\u003E.\u0026nbsp;\u003C\/strong\u003E\u003C\/p\u003E\u003Cp dir=\u0022ltr\u0022\u003E\u201cAs the wife of a Georgia Tech graduate and an individual with pseudoexfoliation glaucoma, I was inspired to support the scientists whose efforts may help me and others,\u201d Jennifer Rucker says.\u003Cstrong\u003E\u0026nbsp;\u003C\/strong\u003EWhat followed was a meaningful dialogue and a shared sense of purpose \u2014 and the creation of the Georgia Tech Glaucoma Research Fund (Wreck Glaucoma! Fund).\u0026nbsp;\u003C\/p\u003E\u003Cp dir=\u0022ltr\u0022\u003E\u201cIt meant so much that Jennifer took the initiative to reach out to learn more about our research,\u201d says Lieberman. \u201cMoments like this remind me how deeply meaningful it is to connect with people in the broader community who are navigating glaucoma. Opportunities for such personal connections are rare, but they inspire and further motivate us to achieve our lab\u2019s mission to improve the lives of individuals suffering from blindness diseases.\u201d\u003C\/p\u003E\u003Ch3\u003E\u003Cstrong\u003EA Personal Connection\u003C\/strong\u003E\u003C\/h3\u003E\u003Cp dir=\u0022ltr\u0022\u003EYoungblood\u2019s interest in glaucoma research also stems from a personal connection: her father\u0026nbsp;was diagnosed with glaucoma as a young adult.\u0026nbsp;Now, Youngblood\u0026nbsp;studies the genetic and molecular factors behind XFG in the\u0026nbsp;\u003Ca href=\u0022https:\/\/lieberman.chemistry.gatech.edu\/\u0022\u003ELieberman research lab\u003C\/a\u003E.\u0026nbsp;\u003C\/p\u003E\u003Cp dir=\u0022ltr\u0022\u003E\u201cXFG is an aggressive form of the disease with no known cure,\u201d Youngblood says.\u003Cstrong\u003E\u0026nbsp;\u003C\/strong\u003EWhile scientists know that XFG is the result of abnormal accumulation of proteins in the eye, current treatments only address symptoms rather than treating the root cause of the disease.\u003C\/p\u003E\u003Cp dir=\u0022ltr\u0022\u003E\u201cWe know XFG is driven by protein buildup, but we still don\u2019t know\u0026nbsp;\u003Cem\u003Ewhy\u003C\/em\u003E it happens,\u201d she explains. \u201cMy work studying specific genetic variants aims to uncover this.\u201d\u0026nbsp;\u003C\/p\u003E\u003Ch3\u003E\u003Cstrong\u003EThe Genetics of Glaucoma\u003C\/strong\u003E\u003C\/h3\u003E\u003Cp dir=\u0022ltr\u0022\u003EIn particular, Youngblood is researching the role of LOXL1, a protein that plays a role in soft tissue throughout the body, including the eyes.\u003C\/p\u003E\u003Cp dir=\u0022ltr\u0022\u003E\u201cResearch has shown that people with variants in the genes responsible for this protein are more likely to have XFG,\u201d she says. \u201cThat made me curious to see if the variants might be impacting the structure of the LOXL1 protein itself and how those variants might lead to disease.\u201d\u003C\/p\u003E\u003Cp dir=\u0022ltr\u0022\u003EYoungblood is currently testing her theory in the lab. \u201cMy hope is that new insight into proteins like LOXL1 will bring us closer to treatments that address XFG at its source,\u201d she says. \u201cThe new Georgia Tech Glaucoma Research Fund is a tremendous step forward in making that hope a reality.\u201d\u003C\/p\u003E\u003Ch3\u003E\u003Cstrong\u003ESupport the Georgia Tech Glaucoma Research Fund\u003C\/strong\u003E\u003C\/h3\u003E\u003Cp dir=\u0022ltr\u0022\u003EPlease visit the \u003Ca href=\u0022https:\/\/giving.gatech.edu\/campaigns\/59801\/donations\/new?designation_id=a000015611000\u0026amp;\u0022\u003EGlaucoma Research Fund support page\u003C\/a\u003E to give to this specific program. To discuss additional philanthropic opportunities, please contact the College of Sciences Development Team:\u0026nbsp;\u003Ca href=\u0022mailto:development@cos.gatech.edu\u0022\u003Edevelopment@cos.gatech.edu\u003C\/a\u003E\u003C\/p\u003E\u003Cp\u003EYour investment ensures that these scholars and researchers have world-class resources, facilities, and mentors to excel in this critical work. Thank you for helping us shape the future.\u003C\/p\u003E","summary":"","format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"\u003Cp\u003EWhen\u0026nbsp;Postdoctoral Research Fellow\u0026nbsp;\u003Cstrong\u003EHannah Youngblood\u003C\/strong\u003E\u2019s\u0026nbsp;work on exfoliation glaucoma (XFG) was featured by the\u0026nbsp;BrightFocus Foundation,\u0026nbsp;it caught the attention of\u0026nbsp;\u003Cstrong\u003EJennifer Rucker,\u0026nbsp;\u003C\/strong\u003Ean Alabama resident who was diagnosed with XFG several years ago. What followed was a meaningful dialogue and a shared sense of purpose \u2014 and the creation of the Georgia Tech Glaucoma Research Fund (Wreck Glaucoma! Fund).\u0026nbsp;\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"When\u00a0Postdoctoral Research Fellow\u00a0Hannah Youngblood\u2019s\u00a0work on exfoliation glaucoma (XFG) was featured by the\u00a0BrightFocus Foundation,\u00a0it caught the attention of\u00a0Jennifer Rucker,\u00a0an Alabama resident who was diagnosed with XFG several years ago. "}],"uid":"35599","created_gmt":"2026-01-29 17:23:21","changed_gmt":"2026-02-19 15:19:24","author":"sperrin6","boilerplate_text":"","field_publication":"","field_article_url":"","location":"Atlanta, GA","dateline":{"date":"2026-02-02T00:00:00-05:00","iso_date":"2026-02-02T00:00:00-05:00","tz":"America\/New_York"},"extras":[],"hg_media":{"679130":{"id":"679130","type":"image","title":"Hannah Youngblood","body":null,"created":"1769722230","gmt_created":"2026-01-29 21:30:30","changed":"1769722339","gmt_changed":"2026-01-29 21:32:19","alt":"Hannah Youngblood","file":{"fid":"263251","name":"Headshot.jpg","image_path":"\/sites\/default\/files\/2026\/01\/29\/Headshot.jpg","image_full_path":"http:\/\/hg.gatech.edu\/\/sites\/default\/files\/2026\/01\/29\/Headshot.jpg","mime":"image\/jpeg","size":42055,"path_740":"http:\/\/hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/2026\/01\/29\/Headshot.jpg?itok=1PjOSH2M"}},"679127":{"id":"679127","type":"image","title":"Raquel Lieberman","body":null,"created":"1769707506","gmt_created":"2026-01-29 17:25:06","changed":"1769722356","gmt_changed":"2026-01-29 21:32:36","alt":"Raquel Lieberman","file":{"fid":"263248","name":"083.jpg","image_path":"\/sites\/default\/files\/2026\/01\/29\/083.jpg","image_full_path":"http:\/\/hg.gatech.edu\/\/sites\/default\/files\/2026\/01\/29\/083.jpg","mime":"image\/jpeg","size":14074756,"path_740":"http:\/\/hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/2026\/01\/29\/083.jpg?itok=qPG_sbYX"}}},"media_ids":["679130","679127"],"related_links":[{"url":"https:\/\/giving.gatech.edu\/campaigns\/59801\/donations\/new?designation_id=a000015611000\u0026","title":"Make a Gift to Support the Georgia Tech Glaucoma Research Fund"}],"groups":[{"id":"1278","name":"College of Sciences"},{"id":"1188","name":"Research Horizons"},{"id":"85951","name":"School of Chemistry and Biochemistry"}],"categories":[{"id":"130","name":"Alumni"},{"id":"138","name":"Biotechnology, Health, Bioengineering, Genetics"},{"id":"193234","name":"Campaign Stories"},{"id":"42901","name":"Community"},{"id":"129","name":"Institute and Campus"},{"id":"146","name":"Life Sciences and Biology"},{"id":"135","name":"Research"},{"id":"134","name":"Student and Faculty"}],"keywords":[{"id":"192249","name":"cos-community"},{"id":"194631","name":"cos-georgia"},{"id":"187423","name":"go-bio"},{"id":"187915","name":"go-researchnews"}],"core_research_areas":[{"id":"39441","name":"Bioengineering and Bioscience"},{"id":"39511","name":"Public Service, Leadership, and Policy"}],"news_room_topics":[{"id":"71891","name":"Health and Medicine"}],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003E\u003Ca href=\u0022mailto:sperrin6@gatech.edu\u0022\u003ESelena Langner\u003C\/a\u003E\u003C\/p\u003E","format":"limited_html"}],"email":[],"slides":[],"orientation":[],"userdata":""}}}